Furthermore, it has recently been established that Orai1 inhibition, using the RP4010 CRAC channel inhibitor, decreased pancreatic cancer cell proliferation through the down-regulation of the AKT/mTOR signaling pathway [63]. This evidence concerns the gene ORAI1 and pancreatic neoplasm.